University of California San Francisco
Give to UCSFAn international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
We asked a team of UCSF kidney experts – including nephrologist, a transplant surgeon, a transplant pharmacist and a bioengineer – to shine a light on the problem of kidney disease and share their hopes for the future.
Fraser discussed science’s evolutionary arms race against bacteria when he delivered the 2020 Byers Award Lecture in Basic Science on March 3.
The study also identified 12 other FDA-approved drugs that are deemed safe in pregnancy.
Researchers screened a massive library of over 150 million virtual molecules and discovered the first drugs that selectively target one of two mammalian melatonin receptors that modulate sleep-wake cycles.
Researchers found that when default settings, showing a preset number of opioid pills, were modified downward, physicians prescribed fewer pills. Fewer pills could improve prescription practices and protect patients from developing opioid addictions.
A survey found that fewer than half of California pharmacies provided antibiotics and opioids disposal instructions meeting U.S. FDA guidelines, and just 10 percent followed the FDA’s preferred recommendation to take back unused medications from their customers.